| |
Group IControl Group
(n=39) |
Group IIPCOS Group
(n=44) |
P |
| Age (years) |
27.5 ± 3.94 |
26.79 ± 3.66 |
NS |
| Age at menarche (years) |
12.48 ± 1.23 |
11.75 ± 1.71 |
<0.05# |
| Oligo-/amenorrhea+/- |
0/39 |
44/0 |
<0.001# |
|
Hirsutism +/− |
0/39 |
35/9 |
<0.001# |
| PCOS on TVU+/− |
ND |
41/3 |
<0.001# |
| Familial history +/− |
4/35 |
14/30 |
<0.05# |
| BMI (kg ⁄m2) |
29.85 ± 2.64 |
30.95 ± 4.07 |
NS |
| WC (cm) |
95.33 ± 10.57 |
97.39 ± 15.37 |
NS |
| HC (cm) |
109.4 ± 9.96 |
113.79 ± 13.06 |
NS |
| WHR |
0.87± 0.05 |
0.85 ± 0.06 |
NS |
| SBP (mmHg) |
113.25 ± 5.72 |
113.02 ± 7.41 |
NS |
| DBP (mmHg) |
73.25 ± 6.16 |
74.65 ± 6.58 |
NS |
| FSH (U/L) |
4.9 ± 1.09 |
4.72 ± 1.22 |
NS |
| LH (U/L) |
4.71 (3.8-6.07) |
8.31 (6.4-9.37) |
<0.001** |
| Testosterone (ng/ml) |
0.8 ± 0.32 |
1.29 ± 0.34 |
<0.001* |
| FBG (mg/dl) |
90.14 ± 9.84 |
107.49 ± 10.89 |
<0.001* |
| FI (uIU/ml) |
14.03 ± 4.47 |
22.52 ± 4.65 |
<0.001* |
| GIR |
6.99 ± 1.98 |
5.49 ± 1.53 |
<0.001* |
| HOMA-IR |
3.17 (2.17-4.23) |
5.73 (4.92-7.39) |
<0.001** |
| QUICKI |
0.326 ± 0.017 |
0.297± 0.01 |
<0.001* |
| sCD40L (ng/ml) |
0.82 (0.43-1.26) |
2.46 (1.08-4.16) |
<0.001** |
PCOS: Polycystic Ovary Syndrome; TVU: Trans-Vaginautrrasonography; BMI: Body Mass Index; WC: Waist Circumference; HC: Hip Circumference; WHR: Waist-To-
Hip Ratio; SBP: Systolic Blood Pressure; DBP: Diastolic Blood Pressure; FSH: Follicle Stimulating Hormone; LH: Luteinizing Hormone; FBG: Fasting Blood Glucose; FI:
Fasting Serum Insulin; GIR: Glucose-To-Insulin Ratio; HOMA-IR: Homeostatic Model Assessment for IR; QUICKI: Quantitative Insulin Sensitivity Check Index; Scd40l:
Soluble CD40L. Values were expressed as Mean ± Standard Deviation [SD] (for normally distributed data), Median and Interquartile range (for non-normally distributed
data), or number (for categorical data). *Analysis using independent student’s T-test, **Analysis using Mann-Whitney’s U-test, #Analysis uing chi-squared (χ2) Test; NS:
Non-Significant |
